Fellow

Bhaven N. Sampat is a Professor at Arizona State University (ASU) and Research Associate at the National Bureau of Economic Research (NBER). He is based at ASU’s Consortium for Science, Policy and Outcomes (CSPO) in Washington DC.

He has written extensively on the Bayh-Dole Act and university patenting, patent examination and patent quality, the effects of the TRIPS agreement on access to medicines, the roles of the public sector in pharmaceutical innovation, patent statistics as economic indicators, and the effects of patents on innovation and competition. This work has appeared in leading journals across various fields, such as Science, Nature, the New England Journal of Medicine, Health Affairs, Management Science, the Journal of Law and Economics, the Review of Economic Studies, and the American Economic Review.

Sampat earned his BA, MA, MPhil, and PhD in Economics from Columbia University. He completed a post-doctoral fellowship through the Robert Wood Johnson Foundation’s Scholars in Health Policy Research program at the University of Michigan. Prior to joining ASU in 2023, he was a professor at Columbia University’s Department of Health Policy and Management.

Sampat is a founding member of the NBER’s Innovation Information Initiative (I3), a data collaborative for open innovation data, analytics, tools, and metrics. He serves on the editorial advisory board of the Milbank Quarterly and is an affiliated professor in the Abdul Latif Jameel Poverty Action Lab (J-PAL) Science for Progress Initiative. His research has been supported by the Robert Wood Johnson Foundation’s Investigator Award in Health Policy Research, the RWJF Public Health Law Research Program, the Commonwealth Fund, the Ford Foundation, the National Science Foundation, and other sources.